A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio Asks Department of Commerce to Answer Questions About Huawei Business Dealings With U.S. Companies
Washington, D.C. — U.S. Senator Marco Rubio (R-FL) sent a letter to U.S. Department of Commerce Secretary Wilbur Ross requesting information concerning Huawei’s orders of semiconductors from American companies.
“I strongly support the actions taken by the Bureau of Industry and Security (BIS) on August 17, 2020, which closed certain loopholes to the Export Administration Regulations (EAR) related to Huawei,” Rubio wrote. “These actions were meant to prevent U.S.-developed technology from being used to undermine our own national security. It has been brought to my attention that Huawei is ordering semiconductors from certain U.S.-based chip companies, or through others stockpiling them, with the intent to ship them in the event that those companies are granted individual export licenses (IVLs), or if Huawei is removed from the Entity List.”
The full text of the letter is below.
Dear Secretary Ross:
As you are well versed, due to its ties to the Chinese Communist Party, Huawei continues to pose a significant threat to the U.S. economy, national security, and our critical infrastructure. I strongly support the actions taken by the Bureau of Industry and Security (BIS) on August 17, 2020, which closed certain loopholes to the Export Administration Regulations (EAR) related to Huawei. These actions were meant to prevent U.S.-developed technology from being used to undermine our own national security.
It has been brought to my attention that Huawei is ordering semiconductors from certain U.S.-based chip companies, or through others stockpiling them, with the intent to ship them in the event that those companies are granted individual export licenses (IVLs), or if Huawei is removed from the Entity List. Accordingly, I respectfully request responses to the following questions:
- Since August 17, 2020, how many IVLs has BIS approved to U.S. semiconductor manufacturers for the purpose of export, re-export or transfer of any item subject to the EAR to Huawei?
- For each IVL, please explain your policy rationale for approval.
- Absent an IVL, would it be legal for a U.S. semiconductor company to stockpile items subject to the EAR for ultimate export, reexport or transfer to Huawei after September 14, 2020, or to receive compensation from Huawei for doing so?
- If so, what is the policy rationale for allowing such stockpiling?
- Does the Administration have any intent to remove Huawei from the Entity List?
For purposes of this inquiry, “Huawei” means Huawei Technologies Co. Ltd, Huawei Investment and Holding Co. Ltd., or any entity with more than 20 percent of the shares of which are ultimately owned by either of the aforementioned. I would appreciate responses to this before December 31, 2020.
Thank you for your attention to this important matter.
Sincerely,